-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On Lakewood-Amedex with Buy Rating, Announces Price Target of $3

Benzinga·10/28/2026 11:04:20
Listen to the news
HC Wainwright & Co. analyst Matthew Keller initiates coverage on Lakewood-Amedex (NASDAQ:LABT) with a Buy rating and announces Price Target of $3.